secwatch.observer — SEC 8-K summary
======================================

Issuer:     iBio, Inc. (IBIO)
CIK:        0001420720
Form:       8-K
Filed at:   2023-01-17T23:59:59+00:00
Accession:  0001420720-23-000002
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iBio CFO Robert Lutz resigns effective February 10, 2023
--------------------------------------------------------

- Robert Lutz, CFO and Chief Business Officer, notified iBio of resignation on January 11, 2023.
- Resignation effective February 10, 2023; Lutz leaving to pursue another opportunity.
- No disagreement with company's strategy, operations, policies, or accounting practices.
- No successor named at this time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420720/000142072023000002/0001420720-23-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420720/000142072023000002/ibio-20230111x8k.htm
  HTML page:      https://secwatch.observer/filing/0001420720-23-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer